| Bioactivity | BET BD2-IN-3 (compound I-58) is an inhibitor of BET, targeting the BD2 domain of BET. BET BD2-IN-3 can be radiolabeled with [11C] for positron emission tomography (PET) imaging. BET [11C]BD2-IN-3 showed suitable biodistribution in peripheral organs and tissues in PET applications in mice[1]. |
| Target | BET BD2 |
| CAS | 2677039-66-4 |
| Formula | C29H30N4O |
| Molar Mass | 450.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Development and Evaluation of [11C]I-58: A Novel PET Radiotracer Targeting BRD4 BD2 for Advanced Epigenetic Imaging |
BET BD2-IN-3
CAS: 2677039-66-4 F: C29H30N4O W: 450.57
BET BD2-IN-3 (compound I-58) is an inhibitor of BET, targeting the BD2 domain of BET. BET BD2-IN-3 can be radiolabeled w
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.